🇺🇸 Randomization between two referenced treatments in United States

Randomization between two referenced treatments (Randomization between two referenced treatments) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Randomization between two referenced treatments in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Randomization between two referenced treatments approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Randomization between two referenced treatments in United States?

University Hospital, Clermont-Ferrand is the originator. The local marketing authorisation holder may differ — check the official source linked above.